22: Non-antibiotic strategy for elimination of intracellular persistence of the uro-pathogenic Escherichia coli




Objectives


CD55, a cell surface complement inhibitory protein serves as a cellular receptor for multiple viruses and bacteria that cause chronic/intracellular infection. Using uropathogenic E. coli, the first CD55-recognizing pathogen described, as a model and a series of CD55 mutants we investigated the mechanism of CD55-mediated invasion and persistence.




Methods


CD55 amino acids in the vicinity of the binding pocket-Ser155 for E. coli Dr adhesin were mutated to alanine and subjected to a modified temporal-gentamicin-invasion/survival assay in Chinese Hamster Ovary cells. CD55/Microtubule (MT) responses were studied using confocal-microscopy, histo-chemistry and 3-D-structure analysis. Mutation at Ser165 decreased Dr+ E. coli internalization by >70% (p<0.05), retained low rate persistence without multiplication and correlated with Ser165Ala disrupted negative-charge distribution.




Methods


CD55 amino acids in the vicinity of the binding pocket-Ser155 for E. coli Dr adhesin were mutated to alanine and subjected to a modified temporal-gentamicin-invasion/survival assay in Chinese Hamster Ovary cells. CD55/Microtubule (MT) responses were studied using confocal-microscopy, histo-chemistry and 3-D-structure analysis. Mutation at Ser165 decreased Dr+ E. coli internalization by >70% (p<0.05), retained low rate persistence without multiplication and correlated with Ser165Ala disrupted negative-charge distribution.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 5, 2017 | Posted by in GYNECOLOGY | Comments Off on 22: Non-antibiotic strategy for elimination of intracellular persistence of the uro-pathogenic Escherichia coli

Full access? Get Clinical Tree

Get Clinical Tree app for offline access